A Structure Therapeutics obesity pill helped patients lose an average of nearly 40 pounds in a mid-stage clinical trial, keeping the drug competitive in the growing crowd of oral medications pursuing ...

People shouldn't be able to move like Florida DT Caleb Banks at 6-6 and 327 pounds. That's a profile you bet on — but it's ...

For decades, scientists have tried and failed to explain how the force that binds the heart of atoms together really works.

The ExoLife Finder (ELF) looks like no telescope ever built. A spectacular crown of 15 five-meter mirrors perches atop a ...

Ty Simpson might be the most intriguing prospect in the 2026 NFL Draft, but how does the Alabama QB measure up against his ...

Cutting Maintenance Costs and Extending Equipment Lifespan with Advanced Magnetic Drive Technology CALIFORNIA, CA, ...

The rights to subsistence and development are the most fundamental human rights. While Japanese representatives declare at ...

In each of the past two seasons, Mark Pope has dealt with issues at the point guard position. How can he avoid it in Year 3?

KVS admission notification for 2026-27 not yet released. Admission process likely to start in March 2026. Two-phase cycle: Balvatika/Class 1 in March, Classes 2-12 in April. Did our AI summary help?

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

CBSE's revised curriculum emphasizes skill-based learning and conceptual understanding, but schools need time to adapt ...

In this travel experience, a passenger flies Turkish Airlines Business Class to see whether it lives up to expectations. While the airline is often known for its service and reputation, the journey ...